肝脏 ›› 2023, Vol. 28 ›› Issue (4): 445-447.

• 肝纤维化及肝硬化 • 上一篇    下一篇

按需内镜治疗在老年肝硬化上消化道出血患者中的疗效评估

忻笑容, 陈平, 吴云林, 蔡波尔, 贺赟, 谢玲   

  1. 201800 上海交通大学医学院附属瑞金医院北部院区消化内科
  • 收稿日期:2022-06-30 出版日期:2023-04-30 发布日期:2023-08-29
  • 通讯作者: 陈平,Email:chenping714@aliyun.com

The efficacy of on-demand endoscopic therapy in elderly patients with upper gastrointestinal bleeding due to liver cirrhosis

XIN Xiao-rong, CHEN Ping, WU Yun-lin, CAI Bo-er, HE Yun, XIE Ling   

  1. Department of Gastroenterology, Ruijin Hospital North,Shanghai Jiaotong University School of Medicine,Shanghai 201800, China
  • Received:2022-06-30 Online:2023-04-30 Published:2023-08-29
  • Contact: CHEN Ping,Email:chenping714@aliyun.com

摘要: 目的 探讨按需内镜治疗在老年肝硬化上消化道出血患者中的疗效,评估其预防出血的作用。方法 2013年1月至2021年1月上海交通大学医学院附属瑞金医院北院院区消化内科收治的肝硬化并发上消化道出血患者186例,均为老年患者。分为内镜治疗组和药物治疗组,各93例。内镜治疗组患者均为初次行内镜下静脉曲张套扎术(endoscopic variceal ligation,EVL),术后定期复查,于3~6个月后序贯内镜治疗。药物治疗组患者仅行药物治疗。分析2组治疗后再发出血的情况。结果 内镜治疗组患者中,13例(14.0%)于EVL术后半年内再发出血;药物治疗组患者中,47例(50.5%)于治疗后半年内再发出血,差异有统计学意义(P<0.05)。随访至1年后,内镜治疗组中7例(7.5%)患者再发出血,药物治疗组中27例(29.0%)再发出血,差异有统计学意义(P<0.05)。分别对两组患者进行半年内再出血相关因素分析,结果年龄、性别、脾脏切除术、Child-Pugh分级均与再次出血无显著相关(P>0.05)。结论 对于老年肝硬化上消化道出血患者,按需内镜治疗安全有效。经内镜序贯治疗后,对比药物治疗组再次发生消化道出血率显著下降。

关键词: 门静脉高压, 上消化道出血, 内镜下静脉曲张套扎术, Child-Pugh评分

Abstract: Objective To analyze the effect of on-demand endoscopic treatment on the prevention of gastrointestinal bleeding in elderly patients with liver cirrhosis. Methods A total of 186 elderly patients with liver cirrhosis complicated with upper gastrointestinal bleeding who were treated in the Department of Gastroenterology, Ruijin Hospital North from January 2013 to January 2021 were collected. According to the treatment plan, they were divided into an endoscopic treatment group and a drug treatment group, with 93 cases in each group. All patients in the endoscopic treatment group underwent endoscopic variceal ligation (EVL) for the first time, followed by regular postoperative follow-up and sequential endoscopic treatment in 3~6 months. The patients in the drug treatment group only received drug treatment. The recurrences of bleeding after treatment in these two groups and the risk factors were analyzed. Results Among the 93 patients in the endoscopic treatment group, 13 patients had re-bleeding within half a year after EVL, accounting for 14.0% (13/93); Among the 93 patients in the drug treatment group, 47 patients had rebleeding within half a year, accounting for 50.5% (47/93). There was significant difference in rebleeding rates between the two groups (P<0.05). After one year of follow-up, 7 patients in the endoscopic treatment group had re-bleeding, accounting for 7.5% (7/93); while 27 cases of rebleeding in the drug treatment group, accounting for 29.0% (27/93). There was significant difference between the two groups (P<0.05). However, age, gender, splenectomy and child-Pugh grade had no significant correlation with rebleeding in half a year (P>0.05). Conclusion For elderly patients with upper gastrointestinal bleeding due to liver cirrhosis, on-demand endoscopic treatment is safe and effective. After sequential endoscopic treatment, the recurrent rate of gastrointestinal bleeding significantly lower than those patients with drug treatment alone.

Key words: Portal hypertension, Upper gastrointestinal bleeding, Endoscopic variceal ligation, Child-Pugh scoring